Active Surveillance

Active surveillance is considered a treatment option if a cancer is not causing any symptoms and is expected to grow slowly. In the past this approach was mainly suggested to elderly men, or men with serious health problems; however, younger men have started to consider this treatment option. Since prostate cancer often spreads very slowly, many men who have the disease may never require treatment. In many men, it is a means of delaying or deferring therapy and potential quality of life changes associated with current treatment options. Typically, patients on an active surveillance program undergo regular PSA measurements and periodic prostate biopsies to ensure that the cancer is not becoming more aggressive. If there is a change in the prostate cancer then the patient can make a decision to undergo active treatment with either surgery or radiation. Approximately 30% of cancers will progress within 5 years. The intent of active surveillance is curative.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Conference Flyer Page 1

Breast & Prostate Cancer half-day virtual conference: Saturday, September 18th, 2021

The What you Need to Know for Your Patients Post Breast & Prostate Cancer Conference, taking place online on Saturday, September 18th, 2021 from 8:00am – 1:30pm, is an accredited virtual half-day conference focusing on screening, treatment, side-effect management & emerging new therapies for breast & prostate cancer patients. Click here for more information and to register. 

Dr. Peter Black, team captain

Terry Fox Run fundraiser: September 19th, 2021

The 41st Annual Terry Fox Run is taking place on Sunday September 19, 2021. If you are able, please consider donating to our team (tax receipts issued), raising funds for the Terry Fox Foundation's ground-breaking cancer research. 

Employment

Work at the Vancouver Prostate Centre

Wednesday, September 8, 2021

Recent publication proposes a potential new therapeutic approach to treatment-resistant prostate cancer

Tuesday, August 3, 2021

Dr. Cherkasov receives 2021 Faculty of Medicine Distinguished Achievement Award

Dr. Cherkasov